KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pacific Biosciences Of California (PACB) Goodwill (2021 - 2026)

Pacific Biosciences Of California has reported Goodwill over the past 5 years, most recently at $317.8 million for Q4 2025.

  • For Q4 2025, Goodwill changed 0.0% year-over-year to $317.8 million; the TTM value through Dec 2025 reached $317.8 million, changed 0.0%, while the annual FY2025 figure was $317.8 million, 0.0% changed from the prior year.
  • Goodwill for Q4 2025 was $317.8 million at Pacific Biosciences Of California, roughly flat from $317.8 million in the prior quarter.
  • Over five years, Goodwill peaked at $463.8 million in Q3 2023 and troughed at $52.3 million in Q4 2023.
  • A 5-year average of $364.8 million and a median of $400.3 million in 2021 define the central range for Goodwill.
  • Biggest five-year swings in Goodwill: tumbled 87.25% in 2023 and later soared 507.72% in 2024.
  • Year by year, Goodwill stood at $410.0 million in 2021, then changed by 0.0% to $410.0 million in 2022, then tumbled by 87.25% to $52.3 million in 2023, then soared by 507.72% to $317.8 million in 2024, then changed by 0.0% to $317.8 million in 2025.
  • Business Quant data shows Goodwill for PACB at $317.8 million in Q4 2025, $317.8 million in Q3 2025, and $317.8 million in Q2 2025.